| Use of V (D) J recombination excision circles to identify T-and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies F Serana, M Chiarini, C Zanotti, A Sottini, D Bertoli, A Bosio, L Caimi, ... Journal of translational medicine 11 (1), 1-11, 2013 | 94 | 2013 |
| The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine … F Serana, A Sottini, M Chiarini, C Zanotti, C Ghidini, A Lanfranchi, ... The Journal of Immunology 185 (12), 7713-7722, 2010 | 77 | 2010 |
| Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma PatientsDTIC plus Vaccination Enlarges … B Palermo, D Del Bello, A Sottini, F Serana, C Ghidini, N Gualtieri, ... Cancer research 70 (18), 7084-7092, 2010 | 56 | 2010 |
| Thymic and bone marrow output in patients with common variable immunodeficiency F Serana, P Airò, M Chiarini, C Zanotti, M Scarsi, M Frassi, V Lougaris, ... Journal of clinical immunology 31, 540-549, 2011 | 50 | 2011 |
| Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19 D Moratto, M Chiarini, V Giustini, F Serana, P Magro, AM Roccaro, ... Journal of Clinical Immunology 40, 970-973, 2020 | 42 | 2020 |
| Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients F Serana, A Sottini, L Caimi, B Palermo, PG Natali, P Nisticò, L Imberti Journal of translational medicine 7, 1-14, 2009 | 40 | 2009 |
| Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients M Chiarini, A Sottini, D Bertoli, F Serana, L Caimi, S Rasia, R Capra, ... Multiple Sclerosis Journal 21 (6), 726-734, 2015 | 39 | 2015 |
| Simultaneous quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) by real-time PCR A Sottini, F Serana, D Bertoli, M Chiarini, M Valotti, MV Tessitore, L Imberti JoVE (Journal of Visualized Experiments), e52184, 2014 | 38 | 2014 |
| T-cell receptor and K-deleting recombination excision circles in newborn screening of T-and B-cell defects: review of the literature and future challenges M Chiarini, C Zanotti, F Serana, A Sottini, D Bertoli, L Caimi, L Imberti Journal of public health research 2 (1), jphr. 2013. e3, 2013 | 33 | 2013 |
| Diagnosis, treatment and long-term follow up of patients with ADA deficiency: a single-center experience R Baffelli, LD Notarangelo, L Imberti, MS Hershfield, F Serana, ... Journal of clinical immunology 35, 624-637, 2015 | 31 | 2015 |
| IFNβ bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays R Capra, A Sottini, C Cordioli, F Serana, M Chiarini, L Caimi, A Padovani, ... Journal of neuroimmunology 189 (1-2), 102-110, 2007 | 31 | 2007 |
| Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients C Zanotti, M Chiarini, F Serana, A Sottini, E Garrafa, F Torri, L Caimi, ... Clinical Immunology 145 (1), 19-26, 2012 | 30 | 2012 |
| Interferon-beta therapy monitoring in multiple sclerosis patients A Sottini, R Capra, F Serana, M Chiarini, L Caimi, L Imberti Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2009 | 26 | 2009 |
| Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1+ patients E Quiros-Roldan, F Serana, M Chiarini, C Zanotti, A Sottini, D Gotti, C Torti, ... Journal of translational medicine 10, 1-11, 2012 | 24 | 2012 |
| MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients F Serana, L Imberti, MP Amato, G Comi, C Gasperini, A Ghezzi, ... PLoS One 9 (4), e94794, 2014 | 22 | 2014 |
| Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy M Chiarini, F Serana, C Zanotti, R Capra, S Rasia, M Rottoli, M Rovaris, ... Multiple Sclerosis Journal 18 (6), 788-798, 2012 | 22 | 2012 |
| Pre-existing T-and B-cell defects in one progressive multifocal leukoencephalopathy patient A Sottini, R Capra, C Zanotti, M Chiarini, F Serana, D Ricotta, L Caimi, ... PLoS One 7 (4), e34493, 2012 | 22 | 2012 |
| Opposite effects of interferon-beta on new B and T cell release from production sites in multiple sclerosis patients C Zanotti, M Chiarini, F Serana, R Capra, M Rottoli, M Rovaris, G Cavaletti, ... Journal of neuroimmunology 240, 147-150, 2011 | 19 | 2011 |
| Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate M Chiarini, A Sottini, C Ghidini, C Zanotti, F Serana, M Rottoli, M Zaffaroni, ... Multiple Sclerosis Journal 16 (2), 218-227, 2010 | 19 | 2010 |
| Bone marrow stroma and vascular contributions to myeloma bone homing M Moschetta, Y Kawano, A Sacco, A Belotti, R Ribolla, M Chiarini, ... Current osteoporosis reports 15, 499-506, 2017 | 17 | 2017 |
